Cite
HARVARD Citation
Nicholson, S. et al. (2020). The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys. British journal of pharmacology. pp. 1061-1076. [Online].